321 related articles for article (PubMed ID: 21998060)
21. [Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: complex clinical situations and real clinical practice].
Tkacheva ON; Akasheva DU
Ter Arkh; 2014; 86(4):103-7. PubMed ID: 24864477
[TBL] [Abstract][Full Text] [Related]
22. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
Hoffman M; Volovyk Z; Monroe DM
Anesthesiology; 2015 Feb; 122(2):353-62. PubMed ID: 25502064
[TBL] [Abstract][Full Text] [Related]
23. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
24. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Bogatkevich GS; Ludwicka-Bradley A; Nietert PJ; Akter T; van Ryn J; Silver RM
Arthritis Rheum; 2011 May; 63(5):1416-25. PubMed ID: 21312187
[TBL] [Abstract][Full Text] [Related]
25. No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.
Bohmann F; Mirceska A; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C; Pfeilschifter W
PLoS One; 2012; 7(7):e40804. PubMed ID: 22911709
[TBL] [Abstract][Full Text] [Related]
26. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
[TBL] [Abstract][Full Text] [Related]
27. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
28. Relation between dabigatran concentration, as assessed using the direct thrombin inhibitor assay, and activated clotting time/activated partial thromboplastin time in patients with atrial fibrillation.
Okubo K; Kuwahara T; Takagi K; Takigawa M; Nakajima J; Watari Y; Nakashima E; Yamao K; Fujino T; Tsutsui H; Takahashi A
Am J Cardiol; 2015 Jun; 115(12):1696-9. PubMed ID: 25918026
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of hematoma expansion in murine warfarin-associated intracerebral hemorrhage.
Illanes S; Zhou W; Heiland S; Markus Z; Veltkamp R
Brain Res; 2010 Mar; 1320():135-42. PubMed ID: 20085756
[TBL] [Abstract][Full Text] [Related]
30. Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
Simonsen CZ; Steiner T; Tietze A; Damgaard D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e133-4. PubMed ID: 24103671
[TBL] [Abstract][Full Text] [Related]
31. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate.
Lindahl TL; Wallstedt M; Gustafsson KM; Persson E; Hillarp A
Thromb Res; 2015 Mar; 135(3):544-7. PubMed ID: 25596769
[TBL] [Abstract][Full Text] [Related]
32. Dabigatran, intracranial hemorrhage, and the neurosurgeon.
Awad AJ; Walcott BP; Stapleton CJ; Yanamadala V; Nahed BV; Coumans JV
Neurosurg Focus; 2013 May; 34(5):E7. PubMed ID: 23634926
[TBL] [Abstract][Full Text] [Related]
33. Intravenous lipid emulsion does not reverse dabigatran-induced anticoagulation in a rat model.
Blum J; Carreiro S; Hack JB
Acad Emerg Med; 2013 Oct; 20(10):1022-5. PubMed ID: 24127705
[TBL] [Abstract][Full Text] [Related]
34. Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model.
Grottke O; van Ryn J; Spronk HM; Rossaint R
Crit Care; 2014 Feb; 18(1):R27. PubMed ID: 24499559
[TBL] [Abstract][Full Text] [Related]
35. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
36. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
37. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
38. The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
Green L; Lawrie AS; Patel R; Stephens RC; Mackie IJ; Chitolie A; Haddad FS; Machin SJ
Thromb Res; 2012 Nov; 130(5):775-9. PubMed ID: 22245224
[TBL] [Abstract][Full Text] [Related]
39. Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.
Schlunk F; Van Cott EM; Hayakawa K; Pfeilschifter W; Lo EH; Foerch C
Stroke; 2012 Jan; 43(1):246-9. PubMed ID: 21998055
[TBL] [Abstract][Full Text] [Related]
40. Reversal of dabigatran-induced bleeding by coagulation factor concentrates in a rat-tail bleeding model and lack of effect on assays of coagulation.
van Ryn J; Schurer J; Kink-Eiband M; Clemens A
Anesthesiology; 2014 Jun; 120(6):1429-40. PubMed ID: 24714118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
